The Nordic Countries - ScanBalt to present at BioEurope 2012, Nov 12 - 14, Hamburg

Monday, 16:00–17:00
Level 1, Room B

Innovative clusters and networks from four countries joined forces to showcase the R&D strength and partnering opportunities from Northern Europe. Nordic countries offer unique biobanks, strong translational R&D centers in oncology, diabetes, neurosciences and other disease areas and dynamic biotech milieus as illustrated by recent success stories such as Algeta and Symphogen. The speakers represent the Oslo Cancer Cluster, the Lund University Diabetes Centre, the Danish Biopeople and BioTurku from Finland. The seminar will update the audience on selected initiatives and developing pipelines and is an invitation to connect for more information on collaborative opportunities.

Speakers:
  • Martin Bonde – CEO, Epitherapeutics and Chairman of Dansk Biotek – Denmark
  • Sylvie Bove – Innovation Officer EXODIAB, Lund University Diabetes Centre – Sweden
  • Tom Pike – Chairman and Director of the Board for several Nordic Biotech companies (Vaccibody, Epitarget, Europharma Nordic, Clanotech, Diagenic, ACD Pharmaceuticals) – Norway
  • Per Walday – CEO, PCI Biotec – Norway
  • Tarja Laitinen – Professor, University of Turku and The Hospital District of Southwest Finland; Coordinator of Clinical Biobanking Network – Finland